Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

U.S. Overdose Deaths Decline for Second Consecutive Year

Drug overdose deaths in the United States decreased in 2025, continuing a downward trend from the previous year. Approximately 70,000 Americans died from overdoses, according to initial government figures.

06/11/2026 · Nevada edition

Advertisement

Advertisement

Preliminary government data indicates that approximately 70,000 Americans died from drug overdoses in 2025. This figure represents a 14% decrease compared to the approximately 81,000 deaths recorded in 2024.

Further analysis and finalized data are expected from the Centers for Disease Control and Prevention later in the year. The CDC plans to release a comprehensive report detailing specific substances involved and demographic breakdowns of the fatalities. The cause of the decline remains under investigation. Public health officials are evaluating several potential factors that may contribute to this trend. These factors include increased access to treatment, expanded harm reduction programs, and changes in the composition of illicit drug supplies.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1104047 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Nevada

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Nevada

health

Transgender Inmates Challenge Federal Prison Policy on Healthcare Access

Attorneys representing transgender inmates have urged the Supreme Court to maintain a lower court's order. This order currently blocks the Federal Bureau of Prisons from enforcing a new policy restricting healthcare and social accommodations for transgender prisoners. The policy, implemented by the Trump administration, eliminates access to hormone therapy and items like makeup and wigs.

Read Story →
health

Government Review Examines Diagnoses of ADHD and Autism in Young People

A recent government review focused on younger individuals and their diagnoses of ADHD and autism. The report highlighted a shift in diagnostic patterns over time. Officials involved in the review acknowledged evolving societal and clinical approaches.

Read Story →
health

Discussion Addresses Mental Health, Suicide Trends in Black Community

NPR's Michel Martin hosted a panel discussion on mental health and suicide within the Black community. The conversation explored the subject through personal perspectives. Participants shared individual experiences.

Read Story →
health

FDA to Conclude Abortion Pill Safety Review by March

The Food and Drug Administration (FDA) will finalize its safety review of mifepristone in March. A Louisiana federal judge mandated this update as part of a legal challenge seeking to reverse a policy allowing mail delivery of the abortion medication.

Read Story →
health

GLP-1 Medications Show Potential in Addressing Addiction

New evidence suggests GLP-1 drugs, commonly used for diabetes and weight loss, may also reduce cravings for addictive substances. Scientists are conducting studies to determine if these medications can help individuals with substance use disorders. This research explores a potential new application for GLP-1s in public health.

Read Story →
health

Report Examines Impact of Trump Administration's Drug Pricing Initiatives

A recent report evaluated the Trump administration's claims regarding drug prices, including the effectiveness of TrumpRx discounts. Findings indicate a mixed impact on prescription drug costs for consumers. The administration has asserted that the U.S. now pays the world's lowest drug prices.

Read Story →
Scroll for more stories